Skip to main content

Israeli pharmaceutical company Teva receives Chinese approval for new Huntington's treatment

The approval to provide the tablets in China that treat the deadly neurological disease is the second in the world after the United States.
The logo of Teva Pharmaceutical Industries is seen during a news conference hold by its CEO, Kare Schultz, to discuss the company's 2019 outlooks in Tel Aviv, Israel February 19, 2019. REUTERS/Amir Cohen - RC16F0E05360

A major Israel-American pharmaceutical company can now sell its medication for treating Huntington’s disease in China. 

Teva Pharmaceuticals received approval from China’s National Medical Products Administration for its Austedo tablets that treat the deadly neurological disease, the company said in a press release today. China is only the second country to approve the use and sale of the Huntington’s medication, Teva Pharmaceuticals said. The other country is the United States.

“We look forward to bringing more of the essential medicines in our portfolio to patients in China, and to fuel organic growth and expand our presence in this important market,” Gianfranco Nazzi, Teva’s executive vice president for international markets, said in the release.

Teva is listed on both the New York and Tel Aviv stock exchanges, and has offices in both Israel and the United States.

Teva Pharmaceuticals praised China’s approval of the medicine. Chinese authorities expedited the approval process of the drug, granting it “priority review,” the company said.

The process was expedited because the medicine is a rare disease treatment, according to Reuters. Austedo is not yet approved by China’s national insurance system, and will only be available to a limited amount of patients at first, the outlet reported.

The approval comes after US criticism of its ally Israel’s relations with China. In Israel last week, US Secretary of State Mike Pompeo said China was not being forthcoming about the coronavirus during a joint press conference with Israeli Prime Minister Benjamin Netanyahu. The United States is also concerned that a Chinese company put in a bid to build what will be the largest water desalination plant in the world off Israel’s southern coast.

In a statement last week, the Chinese Embassy in Israel called Pompeo’s remarks “absurd,” downplayed its economic ties with Israel and criticized US handling of the virus.

The United States is Israel’s main ally and has strong military ties with the Jewish state. US-Chinese relations have sunk to new lows due to trade and now coronavirus issues.

Amid the controversy over China-Israel ties, China’s ambassador to Israel, Du Wei, was found dead in his Tel Aviv home Sunday. China’s Foreign Ministry cited “health reasons” as the preliminary cause of the 57-year-old envoy's death.

Join hundreds of Middle East professionals with Al-Monitor PRO.

Business and policy professionals use PRO to monitor the regional economy and improve their reports, memos and presentations. Try it for free and cancel anytime.

Free

The Middle East's Best Newsletters

Join over 50,000 readers who access our journalists dedicated newsletters, covering the top political, security, business and tech issues across the region each week.
Delivered straight to your inbox.

Free

What's included:
Our Expertise

Free newsletters available:

  • The Takeaway & Week in Review
  • Middle East Minute (AM)
  • Daily Briefing (PM)
  • Business & Tech Briefing
  • Security Briefing
  • Gulf Briefing
  • Israel Briefing
  • Palestine Briefing
  • Turkey Briefing
  • Iraq Briefing
Expert

Premium Membership

Join the Middle East's most notable experts for premium memos, trend reports, live video Q&A, and intimate in-person events, each detailing exclusive insights on business and geopolitical trends shaping the region.

$25.00 / month
billed annually

Become Member Start with 1-week free trial

We also offer team plans. Please send an email to pro.support@al-monitor.com and we'll onboard your team.

What's included:
Our Expertise AI-driven

Memos - premium analytical writing: actionable insights on markets and geopolitics.

Live Video Q&A - Hear from our top journalists and regional experts.

Special Events - Intimate in-person events with business & political VIPs.

Trend Reports - Deep dive analysis on market updates.

All premium Industry Newsletters - Monitor the Middle East's most important industries. Prioritize your target industries for weekly review:

  • Capital Markets & Private Equity
  • Venture Capital & Startups
  • Green Energy
  • Supply Chain
  • Sustainable Development
  • Leading Edge Technology
  • Oil & Gas
  • Real Estate & Construction
  • Banking

Already a Member? Sign in

Start your PRO membership today.

Join the Middle East's top business and policy professionals to access exclusive PRO insights today.

Join Al-Monitor PRO Start with 1-week free trial